Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis
Abstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly cor...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.15612 |
id |
doaj-41b3c62de62044a297cb6844ac34e355 |
---|---|
record_format |
Article |
spelling |
doaj-41b3c62de62044a297cb6844ac34e3552020-11-25T01:58:53ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762019-11-013362635264310.1111/jvim.15612Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysisAndré Nanny Vieira Le Sueur0Silvano Salgueiro Geraldes1Alessandra Melchert2Regina Kiomi Takahira3Michael Coyne4Rachel Murphy5Donald Szlosek6Priscylla Tatiana Chalfun Guimarães‐Okamoto7Department of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilIDEXX Laboratories Inc Westbrook MaineIDEXX Laboratories Inc Westbrook MaineIDEXX Laboratories Inc Westbrook MaineDepartment of Veterinary Clinics, School of Veterinary Medicine and Animal Science São Paulo State University—UNESP São Paulo BrazilAbstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly correlated with glomerular filtration rate (GFR) in animals and humans and is an earlier indicator of kidney dysfunction than serum creatinine concentration (sCr). Objectives To evaluate and quantify the effects of IV fluid therapy (IF) or intermittent hemodialysis (IH) on renal function in a randomized group of dogs previously diagnosed with International Renal Interest Society (IRIS) stage 4 chronic kidney disease (CKD). Animals Twenty‐four client‐owned dogs with naturally occurring CKD. Methods Serum from 14 dogs treated by IH and 10 dogs treated with IF was submitted for measurement of sCr and SDMA. Dogs in each treatment group received up to 5 treatment sessions, administered 48 hours apart. Results Significant differences (P ≤ .05) were seen between treatment groups, but dogs from the IH group were the most affected based on SDMA (P < .001), sCr (P < .001), and blood urea (P < .001) concentrations. Furthermore, for each 10% increase in urea reduction ratio, there was a 6.2 μg/dL decrease in SDMA (P = .002). Conclusions and Clinical Importance Although SDMA is dialyzable biomarker and despite its removal by IH, SDMA correlates better with renal function than does sCr in dogs with CKD undergoing IF and IH.https://doi.org/10.1111/jvim.15612caninedialysisglomerular filtration rateSDMA renal biomarker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
André Nanny Vieira Le Sueur Silvano Salgueiro Geraldes Alessandra Melchert Regina Kiomi Takahira Michael Coyne Rachel Murphy Donald Szlosek Priscylla Tatiana Chalfun Guimarães‐Okamoto |
spellingShingle |
André Nanny Vieira Le Sueur Silvano Salgueiro Geraldes Alessandra Melchert Regina Kiomi Takahira Michael Coyne Rachel Murphy Donald Szlosek Priscylla Tatiana Chalfun Guimarães‐Okamoto Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis Journal of Veterinary Internal Medicine canine dialysis glomerular filtration rate SDMA renal biomarker |
author_facet |
André Nanny Vieira Le Sueur Silvano Salgueiro Geraldes Alessandra Melchert Regina Kiomi Takahira Michael Coyne Rachel Murphy Donald Szlosek Priscylla Tatiana Chalfun Guimarães‐Okamoto |
author_sort |
André Nanny Vieira Le Sueur |
title |
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
title_short |
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
title_full |
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
title_fullStr |
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
title_full_unstemmed |
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
title_sort |
symmetric dimethylarginine concentrations in dogs with international renal interest society stage 4 chronic kidney disease undergoing intermittent hemodialysis |
publisher |
Wiley |
series |
Journal of Veterinary Internal Medicine |
issn |
0891-6640 1939-1676 |
publishDate |
2019-11-01 |
description |
Abstract Background Symmetric dimethylarginine (SDMA) is a methylated arginine derived from intranuclear methylation of l‐arginine by protein‐arginine methyltransferase and released into circulation after proteolysis. It is primarily eliminated by renal excretion, and its concentration is highly correlated with glomerular filtration rate (GFR) in animals and humans and is an earlier indicator of kidney dysfunction than serum creatinine concentration (sCr). Objectives To evaluate and quantify the effects of IV fluid therapy (IF) or intermittent hemodialysis (IH) on renal function in a randomized group of dogs previously diagnosed with International Renal Interest Society (IRIS) stage 4 chronic kidney disease (CKD). Animals Twenty‐four client‐owned dogs with naturally occurring CKD. Methods Serum from 14 dogs treated by IH and 10 dogs treated with IF was submitted for measurement of sCr and SDMA. Dogs in each treatment group received up to 5 treatment sessions, administered 48 hours apart. Results Significant differences (P ≤ .05) were seen between treatment groups, but dogs from the IH group were the most affected based on SDMA (P < .001), sCr (P < .001), and blood urea (P < .001) concentrations. Furthermore, for each 10% increase in urea reduction ratio, there was a 6.2 μg/dL decrease in SDMA (P = .002). Conclusions and Clinical Importance Although SDMA is dialyzable biomarker and despite its removal by IH, SDMA correlates better with renal function than does sCr in dogs with CKD undergoing IF and IH. |
topic |
canine dialysis glomerular filtration rate SDMA renal biomarker |
url |
https://doi.org/10.1111/jvim.15612 |
work_keys_str_mv |
AT andrenannyvieiralesueur symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT silvanosalgueirogeraldes symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT alessandramelchert symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT reginakiomitakahira symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT michaelcoyne symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT rachelmurphy symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT donaldszlosek symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis AT priscyllatatianachalfunguimaraesokamoto symmetricdimethylarginineconcentrationsindogswithinternationalrenalinterestsocietystage4chronickidneydiseaseundergoingintermittenthemodialysis |
_version_ |
1724967447083089920 |